Patent · US Active

IAP BIR domain binding compounds

US7795298B2 · kind B2 · utility

0Cited by
10References
33Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 4, 2006
Grant dateSep 14, 2010
Priority date
Expiry dateFeb 6, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is an isomer, enantiomer, diastereoisomer or tautomer of a compound represented by Formula I:or a salt thereof, in which R1, R2, R100, R200, A, A1, B, B1, BG, n, Q and Q1 are substituents described. Also disclosed is the use of compounds of Formula 1 to treat proliferative disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.